Clinical Trial Update: Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating Serplulimab in combination with first-line targeted therapy, chemotherapy, and radiation for advanced colorectal cancer; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Fudan University | Conditions: Advanced Colorectal Carcinoma, Immunotherapy | Phase 2 | Status: RECRUITING